Dynavax Technologies
DVAX
#5495
Rank
HK$9.95 B
Marketcap
HK$84.78
Share price
-0.64%
Change (1 day)
-15.51%
Change (1 year)

Dynavax Technologies (DVAX) - Net assets

Net assets on the balance sheet as of September 2025 : HK$4.15 Billion

According to Dynavax Technologies 's latest financial reports the company has HK$4.15 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Dynavax Technologies - Net assets on balance sheet (from 2003 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$HK$4.63 B-4.63%
2023-12-31$HK$4.85 B7.02%
2022-12-31$HK$4.53 B161.8%
2021-12-31$HK$1.73 B281.09%
2020-12-31$HK$0.45 B604.73%
2019-12-31$HK$64.56 M-86.93%
2018-12-31$HK$0.49 B-68.32%
2017-12-31$HK$1.55 B125.39%
2016-12-31$HK$0.69 B-52.3%
2015-12-31$HK$1.44 B86.04%
2014-12-31$HK$0.77 B-46.05%
2013-12-31$HK$1.44 B62.31%
2012-12-31$HK$0.89 B14.73%
2011-12-31$HK$0.77 B91.29%
2010-12-31$HK$0.40 B720.3%
2009-12-31$HK$49.43 M-60.4%
2008-12-31$HK$0.12 B-59.08%
2007-12-31$HK$0.30 B-50.39%
2006-12-31$HK$0.61 B6.66%
2005-12-31$HK$0.57 B23.91%
2004-12-31$HK$0.46 B-204.95%
2003-12-31$-HK$0.45 Billion0.85%
2002-12-31$-HK$0.44 Billion63.81%
2001-12-31$-HK$0.27 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Agenus
AGEN
-HK$2.19 Billion-152.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$141.73 B 3,308.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$404.07 B 9,617.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$167.02 B 3,916.94%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$357.86 B 8,506.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
HK$164.84 B 3,864.52%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
HK$724.72 B 17,329.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$56.47 B 1,258.08%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
HK$74.88 B 1,700.85%๐Ÿ‡บ๐Ÿ‡ธ USA